PT66067B - Process for preparing novel anthracycline glycosides - Google Patents

Process for preparing novel anthracycline glycosides

Info

Publication number
PT66067B
PT66067B PT66067A PT6606777A PT66067B PT 66067 B PT66067 B PT 66067B PT 66067 A PT66067 A PT 66067A PT 6606777 A PT6606777 A PT 6606777A PT 66067 B PT66067 B PT 66067B
Authority
PT
Portugal
Prior art keywords
preparing novel
anthracycline glycosides
novel anthracycline
glycosides
preparing
Prior art date
Application number
PT66067A
Other languages
English (en)
Portuguese (pt)
Other versions
PT66067A (en
Original Assignee
Gosalvez Mario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gosalvez Mario filed Critical Gosalvez Mario
Publication of PT66067A publication Critical patent/PT66067A/pt
Publication of PT66067B publication Critical patent/PT66067B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT66067A 1976-01-16 1977-01-13 Process for preparing novel anthracycline glycosides PT66067B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES444380A ES444380A1 (es) 1976-01-16 1976-01-16 Un procedimiento para preparar derivados metalicos antraci- clinicos.

Publications (2)

Publication Number Publication Date
PT66067A PT66067A (en) 1977-02-01
PT66067B true PT66067B (en) 1978-06-23

Family

ID=8470743

Family Applications (1)

Application Number Title Priority Date Filing Date
PT66067A PT66067B (en) 1976-01-16 1977-01-13 Process for preparing novel anthracycline glycosides

Country Status (29)

Country Link
US (1) US4138480A (enExample)
JP (1) JPS52111555A (enExample)
AR (1) AR218620A1 (enExample)
AT (1) AT349634B (enExample)
AU (1) AU513698B2 (enExample)
BE (1) BE850438A (enExample)
CA (1) CA1070680A (enExample)
CH (1) CH629219A5 (enExample)
DD (1) DD129452A5 (enExample)
DE (1) DE2701405C2 (enExample)
DK (1) DK11877A (enExample)
EG (1) EG12735A (enExample)
ES (1) ES444380A1 (enExample)
FI (1) FI770115A7 (enExample)
FR (1) FR2338285A1 (enExample)
GB (1) GB1568263A (enExample)
GR (1) GR70696B (enExample)
HU (1) HU177832B (enExample)
IE (1) IE44689B1 (enExample)
IL (1) IL51264A (enExample)
NL (1) NL7700379A (enExample)
NO (1) NO770122L (enExample)
NZ (1) NZ183084A (enExample)
PH (1) PH16582A (enExample)
PL (1) PL108660B1 (enExample)
PT (1) PT66067B (enExample)
SE (1) SE7700398L (enExample)
SU (1) SU886748A3 (enExample)
YU (1) YU5477A (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2959798A (en) * 1958-03-24 1960-11-15 Champlin Oil & Refining Co Pipe line cleaner
US4337335A (en) * 1978-05-18 1982-06-29 Schering Corporation Transition metal salt complexes of polyamino organic compounds
IT1184161B (it) * 1985-03-14 1987-10-22 Franco Conti Derivati del chitosano costituiti da complessi di coordinazione con ioni ferrosi
JPS63310830A (ja) * 1987-06-10 1988-12-19 Meiji Seika Kaisha Ltd 抗レトロウイルス剤
GB9613182D0 (en) * 1996-06-24 1996-08-28 Nycomed Imaging As Method
NL1009226C2 (nl) * 1998-05-20 1999-11-24 Faculteit Geneeskunde Universi Toepassing van een nucleïnezuur-bindend chemotherapeutisch agens, een farmaceutisch preparaat en een geneesmiddelcombinatie.
WO2004087097A2 (en) * 2003-03-31 2004-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
US7053191B2 (en) * 2003-05-21 2006-05-30 Solux Corporation Method of preparing 4-R-substituted 4-demethoxydaunorubicin
AU2005303389A1 (en) * 2004-11-15 2006-05-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Combination therapy associating preferably a ceramide with a cytotoxic drug
WO2008100591A2 (en) * 2007-02-14 2008-08-21 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
EP3327148B1 (en) 2010-06-18 2021-03-17 Myriad Genetics, Inc. Methods of predicting the status of brca1 and brca2 genes in a cancer cell
ES2704303T3 (es) 2010-08-24 2019-03-15 Dana Farber Cancer Inst Inc Procedimientos para la predicción de una respuesta contra el cáncer
ES2768344T3 (es) 2011-06-17 2020-06-22 Myriad Genetics Inc Métodos y materiales para evaluar el desequilibrio alélico
JP6325453B2 (ja) 2011-12-21 2018-05-16 ミリアド・ジェネティックス・インコーポレイテッド ヘテロ接合性の消失(lossofheterozygosity)を評価するための方法および材料
ES2687024T3 (es) 2012-02-23 2018-10-23 Children's Medical Center Corporation Procedimientos para predecir la respuesta contra el cáncer
CA2867434C (en) 2012-06-07 2021-10-12 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
DK2981624T3 (da) 2013-04-05 2020-03-02 Myriad Genetics Inc Fremgangsmåder til vurdering af homolog rekombinationsdeficiens og forudsigelse af respons på cancerbehandling
CA2931181C (en) 2013-12-09 2023-01-24 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
DK3686288T3 (da) 2014-08-15 2023-05-22 Myriad Genetics Inc Fremgangsmåder og materialer til analyse af homolog rekombinationsdeficiens
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3074927A (en) * 1960-04-12 1963-01-22 Paul D Saltman Metallic complexes of reducing sugars
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1469430A (en) * 1974-12-24 1977-04-06 Farmaceutici Italia Daunomycin derivatives

Also Published As

Publication number Publication date
DE2701405A1 (de) 1977-07-21
DE2701405C2 (de) 1986-02-27
JPS6133039B2 (enExample) 1986-07-31
PL108660B1 (en) 1980-04-30
EG12735A (en) 1981-03-31
FI770115A7 (enExample) 1977-07-17
IE44689L (en) 1977-07-16
DK11877A (da) 1977-07-17
CH629219A5 (de) 1982-04-15
NL7700379A (nl) 1977-07-19
HU177832B (en) 1981-12-28
IL51264A0 (en) 1977-03-31
NO770122L (no) 1977-07-19
DD129452A5 (de) 1978-01-18
AT349634B (de) 1979-04-10
GR70696B (enExample) 1982-12-30
PH16582A (en) 1983-11-22
SU886748A3 (ru) 1981-11-30
JPS52111555A (en) 1977-09-19
IL51264A (en) 1980-05-30
PT66067A (en) 1977-02-01
YU5477A (en) 1982-06-30
FR2338285B1 (enExample) 1980-03-14
CA1070680A (en) 1980-01-29
FR2338285A1 (fr) 1977-08-12
NZ183084A (en) 1980-04-28
AR218620A1 (es) 1980-06-30
PL195344A1 (pl) 1978-08-14
ES444380A1 (es) 1977-06-16
US4138480A (en) 1979-02-06
ATA19677A (de) 1978-09-15
AU513698B2 (en) 1980-12-18
GB1568263A (en) 1980-05-29
BE850438A (fr) 1977-05-16
IE44689B1 (en) 1982-02-24
AU2131977A (en) 1978-07-20
SE7700398L (sv) 1977-07-17

Similar Documents

Publication Publication Date Title
PT66067A (en) Process for preparing novel anthracycline glycosides
HK1182A (en) Anthracycline glycosides
PT66311B (en) Process for preparing hentriakontapeptides
PT68857A (en) Process for preparing pleuromutitin glycoside derivatives
YU40483B (en) Process for preparing anthracycline antibiotetics
PT67429A (en) Process for preparing novel nucleosides
JPS5334737A (en) Process for preparing 22oxybenzaldehyde
JPS5382707A (en) Process for preparing alphaaaminoamid
YU269977A (en) Process for obtaining new anthracyline glycoside compounds
JPS5363304A (en) Process for preparing ethylfneglycol
JPS5365813A (en) Process for preparing 22methyll22heptenee66one
NZ186047A (en) Anthracycline glycosides
YU43412B (en) Process for producing the anthracycline complex of baumycine
DE3065832D1 (en) Process for producing anthracycline glycosides
JPS5299996A (en) Process for preparing betaaal2o3
GB2021571B (en) Anthracycline glycosides
NZ186048A (en) Anthracycline glycosides
JPS5365820A (en) Process for preparing pure llsystine
GB2021572B (en) Anthracycline glycosides
JPS5371054A (en) Process for preparing 17alphaa hydroxyy211acetoxyyprogesteron
JPS5379831A (en) Process for preparing diphenyethers
GB2034707B (en) anthracycline glycosides
JPS52111592A (en) Process for preparing 33methylene cephalospolines
JPS5373597A (en) Process for preparing 33heterothiomethylcepualospolines
PT67000A (en) Process for preparing novel anhydro sugars